E. Kuvardin, D. Y. Andreev, P. A. Yastrebov, V. Myachikova, D. Bukhanova, D. V. Karpova, K. Malikov, M. Samsonov, A. Maslyanskiy
{"title":"弥漫性系统性硬化症患者olokizumab治疗的临床病例","authors":"E. Kuvardin, D. Y. Andreev, P. A. Yastrebov, V. Myachikova, D. Bukhanova, D. V. Karpova, K. Malikov, M. Samsonov, A. Maslyanskiy","doi":"10.47360/1995-4484-2022-603-608","DOIUrl":null,"url":null,"abstract":"Treatment algorithms for systemic sclerosis have not been completely developed. Effectivity of medications are usually used in clinical practice has a low level of evidence. Therefore, it is necessary to find a new treatment approaches for this nosological form. In the paper described clinical case of olokizumab treatment in a patient with diffuse systemic sclerosis with interstitial lung disease, polyserositis, severe microcirculatory alterations.","PeriodicalId":21518,"journal":{"name":"Rheumatology Science and Practice","volume":"177 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Clinical case of olokizumab treatment in a patient with diffuse systemic sclerosis\",\"authors\":\"E. Kuvardin, D. Y. Andreev, P. A. Yastrebov, V. Myachikova, D. Bukhanova, D. V. Karpova, K. Malikov, M. Samsonov, A. Maslyanskiy\",\"doi\":\"10.47360/1995-4484-2022-603-608\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Treatment algorithms for systemic sclerosis have not been completely developed. Effectivity of medications are usually used in clinical practice has a low level of evidence. Therefore, it is necessary to find a new treatment approaches for this nosological form. In the paper described clinical case of olokizumab treatment in a patient with diffuse systemic sclerosis with interstitial lung disease, polyserositis, severe microcirculatory alterations.\",\"PeriodicalId\":21518,\"journal\":{\"name\":\"Rheumatology Science and Practice\",\"volume\":\"177 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-11-11\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Rheumatology Science and Practice\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.47360/1995-4484-2022-603-608\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Rheumatology Science and Practice","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.47360/1995-4484-2022-603-608","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Clinical case of olokizumab treatment in a patient with diffuse systemic sclerosis
Treatment algorithms for systemic sclerosis have not been completely developed. Effectivity of medications are usually used in clinical practice has a low level of evidence. Therefore, it is necessary to find a new treatment approaches for this nosological form. In the paper described clinical case of olokizumab treatment in a patient with diffuse systemic sclerosis with interstitial lung disease, polyserositis, severe microcirculatory alterations.